GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Cyclically Adjusted FCF per Share

Medy-Tox (XKRX:086900) Cyclically Adjusted FCF per Share : ₩242.96 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Medy-Tox's adjusted free cash flow per share for the three months ended in Dec. 2023 was ₩-1,614.072. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩242.96 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Medy-Tox's average Cyclically Adjusted FCF Growth Rate was -54.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -25.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -20.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Medy-Tox was -13.30% per year. The lowest was -25.10% per year. And the median was -16.50% per year.

As of today (2024-05-16), Medy-Tox's current stock price is ₩135500.00. Medy-Tox's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was ₩242.96. Medy-Tox's Cyclically Adjusted Price-to-FCF of today is 557.70.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medy-Tox was 1118.24. The lowest was 103.86. And the median was 336.70.


Medy-Tox Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Medy-Tox's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Cyclically Adjusted FCF per Share Chart

Medy-Tox Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 917.93 577.62 564.48 533.83 242.96

Medy-Tox Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 533.83 432.03 513.20 494.16 242.96

Competitive Comparison of Medy-Tox's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Medy-Tox's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medy-Tox's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medy-Tox's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medy-Tox's Cyclically Adjusted Price-to-FCF falls into.



Medy-Tox Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medy-Tox's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1614.072/118.8477*118.8477
=-1,614.072

Current CPI (Dec. 2023) = 118.8477.

Medy-Tox Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 9,788.150 99.253 11,720.544
201406 -21.178 99.353 -25.333
201409 2,143.879 99.608 2,557.978
201412 843.052 99.098 1,011.068
201503 -356.622 99.720 -425.027
201506 -606.470 100.050 -720.415
201509 -1,188.568 100.110 -1,411.034
201512 403.678 100.220 478.709
201603 -763.003 100.560 -901.762
201606 -732.173 100.790 -863.350
201609 -12,218.617 101.460 -14,312.582
201612 -140.439 101.560 -164.345
201703 332.942 102.850 384.729
201706 -1,507.680 102.610 -1,746.265
201709 -610.717 103.490 -701.346
201712 3,784.180 102.990 4,366.842
201803 4,311.726 104.100 4,922.562
201806 -398.602 104.130 -454.940
201809 915.705 105.650 1,030.094
201812 2,048.920 104.350 2,333.583
201903 1,906.975 104.490 2,169.007
201906 -1,258.069 104.880 -1,425.616
201909 703.859 105.200 795.171
201912 223.257 105.120 252.412
202003 -125.154 105.540 -140.935
202006 -1,041.741 104.870 -1,180.590
202009 4,075.929 106.200 4,561.345
202012 -5,697.177 105.765 -6,401.870
202103 -2,971.485 107.357 -3,289.525
202106 1,156.529 107.579 1,277.678
202109 592.921 108.759 647.920
202112 1,159.732 109.676 1,256.710
202203 1,208.883 111.806 1,285.022
202206 -1,477.146 114.083 -1,538.842
202209 391.587 114.831 405.283
202212 116.631 115.200 120.324
202303 -1,255.293 116.550 -1,280.045
202306 385.466 117.140 391.086
202309 -942.651 119.111 -940.566
202312 -1,614.072 118.848 -1,614.072

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Medy-Tox  (XKRX:086900) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medy-Tox's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=135500.00/242.96
=557.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medy-Tox was 1118.24. The lowest was 103.86. And the median was 336.70.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Medy-Tox Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medy-Tox (XKRX:086900) Business Description

Industry
Traded in Other Exchanges
N/A
Address
641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines